Skip to main content
. 2014 Jun 27;307(4):L311–L316. doi: 10.1152/ajplung.00128.2014

Table 2.

Clinical characteristics of the COPD patients and healthy controls from ELSA and Whitehall II

WHII
ELSA
Characteristics Cases (n = 318) Controls (n = 1133) P Value Cases (n = 364) Controls (n = 1094) P Value
Age, yr 45.73 ± 6.1 43.43 ± 5.7 <0.001 71.40 ± 9.6 66.03 ± 8.44 <0.001
Male 199 (63%) 860 (76%) <0.001 207 (57%) 510 (47%) <0.001
Ever smoked, % 100 100 100 100
FEV1, liters 2.04 ± 0.68 3.05 ± 0.67 <0.001 1.38 ± 0.60 2.46 ± 0.77 <0.001
FEV1, % predicted 59.16 ± 14.83 84.52 ± 11.79 <0.001 56.16 ± 18.56 99.39 ± 43.43 <0.001
FVC, liters 3.49 ± 0.88 3.96 ± 0.77 <0.001 2.62 ± 0.97 3.20 ± 1.06 <0.001
FEV1/FVC 0.58 ± 0.11 0.77 ± 0.06 <0.001 0.53 ± 0.14 0.78 ± 0.08 <0.001

Data are presented as means ± SD or number with % in parentheses. WHII, Whitehall II.